Subject:Re: C-O-I Survey on NCI Clinical Trials

In response to the message posted on TECHNO-L by Ann Stevens yesterday
concerning a Conflict-of-Interest survey being conducted by grants
management at NCI, I have listed below the questions that caller asked me:
>
> 1.  Does the organization have a written policy guidelines on C-O-I and the
>       avoidance there of?
> 2.  Who is covered under the policy? (e.g., employees, consultants, members
>       of governing bodies)?
> 3.  How does the organization ensure employees' compliance with the policy?
>       How often?
> 4.  Does the organization participate in NCI supported clinical trials?
>       (if no, skip to #5)
>       a.  Are outside investigators and consultants (including members of
>               Data and Safety Monitoring Boards and other advisory groups)
>               in compliance with this policy?
>       b.  How is the compliance of outside investigators and consultants
>               certified?  How often
>       c.  How does the organization ensure that participating institutions
>               have written C-O-I policies and that investigators are in
>               compliance with those policies?
> 5.  How does the organization ensure that consortium institutions have
>       written C-O-I guidelines and that investigators are in compliance
>       with the guidelines?
>
Doug Wilkerson, Ph.D.           VOICE:  (419) 381-4252
Assoc. V.P. for Research        FAX:    (419) 381-4262
Medical College of Ohio         e-mail: xxxxxx@CUTTER.MCO.EDU
3000 Arlington Ave.
Toledo, OH 43614